| Metric | შპს თბილისი მედიკ | შპს ნიუ ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾14.8m₾14.3m | ₾14.6m₾21.9m |
| Revenue growth | 3.5% | -33.2% |
| Profitability | ||
| EBITDA | ₾827k₾1.8m | -₾27k₾3.5m |
| EBITDA margin | 5.6%12.3% | -0.2%15.8% |
| Net profit | -₾2.2m₾1.9m | -₾1.2m₾2.1m |
| Net margin | -14.8%13.2% | -8.4%9.7% |
| Balance sheet | ||
| Total assets | ₾18.7m₾19.7m | ₾9.7m₾10.9m |
| Total equity | ₾14.2m₾16.3m | ₾3.4m₾5.9m |
| ROE | -15.5%11.6% | -35.4%36.1% |